seed
Stage
2020
Founded
1
Investors
About
ATB Therapeutics is a biotech company developing next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. They utilize a proprietary platform to create highly potent and selective ADCs, aiming for improved efficacy and safety in oncology.
Explore ATB Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.